RhoVac

News

Targeting COVID-19 and cancer with immunotherapy advancements

RhoVac pummelled as lead cancer vaccine fails study

Shares in Swedish biotech RhoVac were down 94% in mid-morning trading today after the company revealed a phase 2b trial of its prostate

News

Two women sit side by side in support of each other, one in a white coat and beret, the other in red

NICE guidance calls for quicker diagnosis of PMOS

Women with polyendocrine metabolic ovarian syndrome (PMOS) should be diagnosed sooner and be offered an annual review, according to new NICE guidance.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks